CellaVision AB
STO:CEVI
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
151.0841
296.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CEVI stock under the Base Case scenario is 268.38 SEK. Compared to the current market price of 239 SEK, CellaVision AB is Undervalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
CellaVision AB
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CEVI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
CellaVision AB
Balance Sheet Decomposition
CellaVision AB
Current Assets | 371.2m |
Cash & Short-Term Investments | 122.3m |
Receivables | 130.3m |
Other Current Assets | 118.6m |
Non-Current Assets | 586.1m |
Long-Term Investments | 3.9m |
PP&E | 122.6m |
Intangibles | 459.7m |
Other Non-Current Assets | -1k |
Current Liabilities | 127m |
Accounts Payable | 46.1m |
Other Current Liabilities | 80.9m |
Non-Current Liabilities | 91m |
Long-Term Debt | 21.3m |
Other Non-Current Liabilities | 69.7m |
Earnings Waterfall
CellaVision AB
Revenue
|
726.4m
SEK
|
Cost of Revenue
|
-242.4m
SEK
|
Gross Profit
|
484m
SEK
|
Operating Expenses
|
-300.2m
SEK
|
Operating Income
|
183.8m
SEK
|
Other Expenses
|
-38.7m
SEK
|
Net Income
|
145.1m
SEK
|
Free Cash Flow Analysis
CellaVision AB
SEK | |
Free Cash Flow | SEK |
CEVI Profitability Score
Profitability Due Diligence
CellaVision AB's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
CellaVision AB's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
CEVI Solvency Score
Solvency Due Diligence
CellaVision AB's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Score
CellaVision AB's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CEVI Price Targets Summary
CellaVision AB
According to Wall Street analysts, the average 1-year price target for CEVI is 285.6 SEK with a low forecast of 252.5 SEK and a high forecast of 325.5 SEK.
Dividends
Current shareholder yield for CEVI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
CEVI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Officers
The intrinsic value of one CEVI stock under the Base Case scenario is 268.38 SEK.
Compared to the current market price of 239 SEK, CellaVision AB is Undervalued by 11%.